Table S1.
A list of ADHD medications approved in North American and European countries
| Stimulants/nonstimulants | Medication class | ADHD medications (Medication type, Formulation if available, Manufacturer) |
|---|---|---|
| Nonstimulants | Selective norepinephrine reuptake inhibitor | Strattera® (ATX; Eli Lilly and Company) |
| Atomoxetine Teva (ATX; Teva) | ||
| Alpha-2 adrenergic agonist | Intuniv® (GXR; Shire) | |
| Guanfacine/Guanfasiini immediate release (GIR) | ||
| Kapvay® (clonidine hydrochloride, extended release; Concordia Pharmaceuticals) | ||
| Clonidine immediate release (CIR) | ||
| Stimulants | Methylphenidate | Biphentin® (MPH; Perdue Pharma) |
| Concerta® (MPH; Janssen Pharmaceuticals/ALZA Corporation) | ||
| Daytrana® (MPH; Noven Therapeutics) | ||
| Elmifiten® (dexmethylphenidate; Alfred E Tiefenbacher Gmbh & Co.) | ||
| Equasym XL®/Equasym Retard®/Equasym Depot®/Quasym LP® (MPH; Shire) | ||
| Focalin® (dexmethylphenidate; Novartis) | ||
| Focalin XR® (dexmethylphenidate, extended release; Novartis) | ||
| Metadate® (MPH; UCB Pharma) | ||
| Metadate CD® (MPH, extended release capsules; UCB Pharma) | ||
| Metadate ER® (MPH, extended release tablets; UCB Pharma) | ||
| Medicebran® (MPH; Laboratorios Farmacéuticos Rovi) | ||
| Medikid (MPH) | ||
| Medikinet/Medikinet CR® (MPH; Medice) | ||
| Medikinet® XL (MPH; Medice) | ||
| Medikinet Retard® (MPH; Medice) | ||
| Methylin® (MPH; Mallinckrodt/Shionogi) | ||
| Methylin ER® (MPH, extended release; Mallinckrodt/Shionogi) | ||
| Methylphenidat-1A pharma® (MPH; 1 A Pharma) | ||
| Methylphenidat HEXAL® (MPH; Hexal) | ||
| Methylphenidat-ratiopharm® (MPH; Ratiopharm) | ||
| Methylpheni TAD® (MPH; TAD Pharma GmbH) | ||
| Methylphenidat TB (MPH; Alfred E Tiefenbacher GmbH & Co.) | ||
| Methylfenidaat HCl (MPH, hydrochloride) | ||
| Methylfenidaat HCI AET (MPH, hydrochloride; Alfred E Tiefenbacher GmbH & Co.) | ||
| Motiron® (MPH; Sandoz) | ||
| Methylphenidate Rubio (MPH; Laboratorios Rubió) | ||
| Omozin® (MPH; Laboratorios Rubió) | ||
| Ritalin/Ritaline® (MPH; Novartis) | ||
| Ritalin LA® (MPH, long acting; Novartis) | ||
| Ritalin SR® (MPH, sustained release; Novartis) | ||
| Rubifen® (MPH; Laboratorios Rubió) | ||
| Tifinidat (MPH; Alfred E Tiefenbacher GmbH & Co.) | ||
| Quillivant™ (MPH; Pfizer) | ||
| Quillivant XR™ (MPH, extended release; Pfizer) | ||
| Amphetamine | Adderall® (amphetamine/dextroamphetamine; Shire) | |
| Adderall XR® (AMPH/dextroamphetamine, extended release; Shire) | ||
| Dexedrine® SR (dextroamphetamine, sustained release; Amedra Pharmaceuticals) | ||
| Dexedrine® spansules® (dextroamphetamine; Amedra Pharmaceuticals) | ||
| Dextroamphetamine ER (dextroamphetamine, extended release) | ||
| Desoxyn® (methamphetamine hydrochloride; Recordati Rare Diseases, INC.) | ||
| Dexedrine® (dextroamphetamine; Amedra Pharmaceuticals LLC) | ||
| Dextrostat® (dextroamphetamine; Shire) | ||
| Elvanse® (lisdexamfetamine; Shire) | ||
| LiquADD® (dextroamphetamine; Auriga Laboratories) | ||
| Metamina (dexamfetamin) | ||
| Vyvanse® (lisdexamfetamine; Shire) |
Notes: Intuniv® is approved in the US only; Biphentin® is approved in Canada only; Attentin® is approved in Germany only. Medikinet Retard® (not Medikinet XL®) and Equasym Retard® (not Equasym XL®) are approved in Germany. Equasym XL® is marketed as Metadate CD® in the US.
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ATX, atomoxetine; GXR, guanfacine extended release; GIR, guanfacine immediate release; CIR, clonidine immediate release; MPH, methylphenidate; AMPH, amphetamine.